"They don't have years," says Dr. Caroline Hastings of Children's Hospital & Research Center Oakland in California, who leads the twins' cyclodextrin treatment. "They really had nothing to lose."
Push to spur more drugs for deadly rare diseases →
It's too soon to know how they'll fare, but the family thinks the girls are more alert, and Hastings says tests show their hearing has improved.
Be the first to know